Psychiatric comorbidity in a cohort of heroin and amphetamine users in Perth, Western Australia

Journal of Substance Use

Volumn 8, Issue 3, 2003, Pages 150-154

  Bartu, Anne ^a   Freeman, Nerelie ^a   Gawthorne, Geoff S ^a   Codde, James P ^b   Holman, C D'Arcy J ^b  

^a Drug and Alcohol Office   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Comorbidity; Illicit drug; Record linkage

Indexed keywords

AMPHETAMINE; DIAMORPHINE; METHADONE; OPIATE;

ADULT; ANAMNESIS; ARTICLE; AUSTRALIA; COHORT ANALYSIS; COMMUNITY; COMORBIDITY; CONTROLLED STUDY; COUNSELING; DRUG ABUSE; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; EXPERIENCE; FEMALE; HAZARD ASSESSMENT; HEALTH CARE ACCESS; HEALTH PROGRAM; HOSPITAL ADMISSION; HOSPITAL SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MENTAL DISEASE; MENTAL HEALTH SERVICE; MORBIDITY; PRIORITY JOURNAL; PROBABILITY; PSYCHOLOGIC ASSESSMENT; RISK ASSESSMENT; SCREENING TEST; SUPPORT GROUP; TREATMENT PLANNING; TREATMENT WITHDRAWAL;

EID: 0347599096     PISSN: 14659891     EISSN: None     Source Type: Journal    
DOI: 10.1080/14659890310001600124     Document Type: Article

References (33)

1. Cantwell R, Brewin J, Glazebrook C, Dalkin T, Fox R, Medley I and Harrison G (1999) Prevalence of substance misuse in first-episode psychosis. British Journal of Psychiatry 174: 150-3.
2. Daniels BA, Kirkby KC, Hay DA, Mowry BJ and Jones IH (1998) Predictability of rehospitalisation over 5 years for schizophrenia, bipolar disorder and depression. Australian and New Zealand Journal of Psychiatry 32 (2): 281-6.
3. Darke S, Swift W and Hall W (1994) Prevalence, severity and correlates of psychological morbidity among methadone maintenance clients. Addiction 89 (2): 211-17.
4. Drake RE and Wallach MA (1989) Substance abuse among the chronic mentally ill. Hospital and Community Psychiatry 40 (10): 1041-5.
5. el-Guebaly N (1990) Substance abuse and mental disorders: the dual diagnosis concept. Canadian Journal of Psychiatry 35 (3): 261-7.
6. Grant BF (1995) Comorbidity between DSM-IV drug use disorders and major depression: results of a national survey of adults. Journal of Substance Abuse 7 (4): 481-97.
7. Hansten ML, Downey L, Rosengren DB and Donovan DM (2000) Relationship between follow-up rates and treatment outcomes in substance abuse research: more is better but when is 'enough' enough? Addiction 95 (9): 1403-16.
8. Harrison CA and Abou-Saleh MT (2002) Psychiatric disorders and substance misuse: psychopathology. In: Rassool GH (ed.) Dual Diagnosis: Substance Misuse & Psychiatric Disorders. Blackwell Science: London, pp. 43-57
9. Holman CDJ, Bass AJ, Rouse IL and Hobbs MST (1999) Population-based linkage of health records in Western Australia: development of a health services research linked database. Australia and New Zealand Journal of Public Health 23 (5): 453-9.
10. Johnson ME, Brems C and Burke S (2002) Recognizing comorbidity among drug users in treatment. American Journal of Drug and Alcohol Abuse 28 (2): 243-61.
11. Khantzian EJ (1985) The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. American Journal of Psychiatry 142 (11): 1259-64.
12. Lehman AF, Myers CP and Corry E (1989) Assessment and classification of patients with psychiatric and substance abuse syndromes. Hospital and Community Psychiatry 40 (10): 1019-25.
13. Limbeek JV, Wouters L, Kaplan CD, Geerlings PJ and Alem VV (1992) Prevalence of psychopathology in drug-addicted Dutch. Journal of Substance Abuse Treatment 9 (1): 43-52.
14. Mason BJ, Kocsis JH, Melia D, Khuri ET, Sweeney J, Wells A, Borg L, Millman RB and Kreek MJ (1998) Psychiatric comorbidity in methadone maintained patients. Journal of Addictive Diseases 17 (3): 75-89.
15. Mueser KT, Bellack AS and Blanchard JJ (1992) Comorbidity of schizophrenia and substance abuse: implications for treatment. Journal of Consulting & Clinical Psychology 60 (6): 845-56.
16. Mueser KT, Yarnold PR, Rosenberg SD, Swett Jr C, Miles KM and Hill D (2000) Substance use disorders in hospitalised severely mentally ill psychiatric patients: prevalence, correlates and subgroups. Schizophrenia Bulletin 26 (1): 179-92.
17. Negrete JC, Knapp WP, Douglas DE and Smith WB (1986) Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey. Psychological Medicine 16 (3): 515-20.
18. Nemes S, Wish E, Wraight B and Messina N (2002) Correlates of treatment follow-up difficulty. Substance Use & Misuse 37 (1): 19-45.
19. Nigam R, Schottenfeld R and Kosten TR (1992) Treatment of dual diagnosis patients: a relapse prevention group approach. Journal of Substance Abuse Treatment 9 (9): 305-9.
20. Richard ML, Liskow BI and Perry PJ (1985) Recent psychostimulant use in hospitalized schizophrenics. Journal of Clinical Psychiatry 46 (3): 79-83.
21. Roberts RO, Bergstralh EJ, Schmidt L and Jacobsen SJ (1996) Comparison of self-reported and medical record health care utilization measures. Journal of Clinical Epidemiology 49 (9): 989-95.
22. Rosenthal RN and Miner CK (1997) Differential diagnosis of substance-induced psychosis and schizophrenia in patients with substance use disorders. Schizophrenia Bulletin 23 (2): 187-93.
23. Ross HE, Glaser FB and Germanson T (1988) The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Archives of General Psychiatry 45 (1): 1023-31.
24. Rounsaville BJ and Kleber HD (1985) Untreated opiate addicts: how do they differ from those seeking treatment? Archives of General Psychiatry 42 (11): 1072-7.
25. Rounsaville BJ, Weissman MM, Crits-Christoph K, Wilber C and Kleber H (1982) Diagnosis and symptoms of depression in opiate addicts: course and relation to treatment outcome. Archives of General Psychiatry 39 (2): 151-6.
26. Rounsaville BJ, Kosten TR, Weissman MW, Prusoff B, Pauls D, Anton SF and Merikangas K (1991) Psychiatric disorders in relatives of probands with opiate addiction. Archives of General Psychiatry 48 (1): 33-42.
27. Sacks S (2000) Co-occurring mental and substance abuse disorders: promising approaches and research issues. Substance Use & Misuse 35 (12-14): 2061-93.
28. San L, Torrens M, Tato J, Castillo C, de la Torre R and Arranz B (1998) Monitoring patterns of substance use in drug dependent patients. Journal of Substance Abuse Treatment 15 (5): 425-30.
29. Schneier FR, and Sins SG (1987) A review of psychoactive substance use and abuse in schizophrenia: patterns of drug choice. Journal of Nervous Mental Disease 175 (11): 641-50.
30. Strain EC, Brooner RK and Bigelow GE (1991) Clustering of multiple substance use and psychiatric diagnoses in opiate addicts. Drug & Alcohol Dependence 27 (2): 127-34.
31. Unwin E, Garfield C and Gawthorne G (2003) Record Linkage Methods Used in the Evaluation of Long-Term Health Outcomes for Illicit Drug Users. Epidemiology & Analytical Services, Department of Health: Perth, WA.
32. Wallihan DB, Stump TE and Callahan CM (1999) Accuracy of self-reported health services use and patterns of care among urban older adults. Medical Care 37 (7): 662-70.
33. White V (2001) Australian Secondary Students' Use of Over-the-Counter and Illicit Substances in 1999. Commonwealth Department of Health and Aged Care: Canberra, ACT.